THE CORRELATION BETWEEN LIPID PROFILE AND UTERINE FIBROID
Keywords:
Benign tumors, lipid profile, abnormal menstrual bleeding, uterine fibroid, women.Abstract
Summary: Uterine fibroids are benign tumors of the uterus and are the most common type. Many women of childbearing age experience them for unknown causes. The primary purpose of our study was to assess the lipid profile of uterine fibroid patients and to compare the lipid profile of healthy women. Methods: This is a case-control study that included 100 women who attended the outpatient clinic and gynecological wards of the Department of Obstetrics and Gynecology at Al-Basra hospital from 1st of January 2020 to 1st of April 2020. The age, parity, and body mass index (BMI) of each participant were noted. For patients with uterine fibroids, we recorded the size, number, and location of the fibroids. Also, a lipid profile was measured. The results were analyzed using SPSS version 23. Results: indicated that the main complaint was abnormal menstrual bleeding. Most of the patients were older than 40 years. Cholesterol levels were significantly higher in the case group. Both groups had similar outcomes in terms of various lipid profiles. The lipid profile was not correlated with the largest diameter of the uterine fibroid (p > 0.05). Conclusion: the data showed that the lipid profile of women with uterine fibroids was different from that of women without these tumors.
References
1. Drayer SM, Catherino WH. Prevalence, morbidity, and current medical management of uterine leiomyomas. International Journal of Gynecology & Obstetrics. 2015;131(2):117-22.
2. Islam MS, Protic O, Giannubilo SR, Toti P, Tranquilli AL, Petraglia F, et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. The Journal of Clinical Endocrinology & Metabolism. 2013;98(3):921-34.
3. Bulun SE. Uterine fibroids. New England Journal of Medicine. 2013;369(14):1344-55.
4. Kim JJ, Sefton EC. The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Molecular and cellular endocrinology. 2012;358(2):223-31.
5. Sankaran S, Manyonda IT. Medical management of fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology. 2008;22(4):655-76.
6. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. American journal of obstetrics and gynecology. 2003;188(1):100-7.
7. Donnez J, Donnez O, Dolmans M-M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? Fertility and sterility. 2014;102(3):640-8.
8. Donnez J, Jadoul P. What are the implications of myomas on fertility? A need for a debate? Human reproduction. 2002;17(6):1424-30.
9. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treatment. American family physician. 2007;75(10):1503-8.
Chapter six
10. Chalas E, Costantino JP, Wickerham DL, Wolmark N, Lewis GC, Bergman C, et al. Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial. American journal of obstetrics and gynecology. 2005;192(4):1230-7.
11. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstetrics and gynecology. 2005;105(3):563.
12. Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound screening study. Obstetrics and gynecology. 2009;113(3):630.
13. Eskenazi B, Warner M, Samuels S, Young J, Gerthoux PM, Needham L, et al. Serum dioxin concentrations and risk of uterine leiomyoma in the Seveso Women's Health Study. American journal of epidemiology. 2007;166(1):79-87.
14. Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Human reproduction update. 2001;7(1):8-14.
15. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, Missmer SA, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. American journal of epidemiology. 2005;161(7):628-38.
16. Munro MG, Critchley HO, Broder MS, Fraser IS, Disorders FWGoM. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. International Journal of Gynecology & Obstetrics. 2011;113(1):3-13.
17. Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best practice & research Clinical obstetrics & gynaecology. 2008;22(4):615-26.
18. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data. American journal of obstetrics and gynecology. 2004;190(5):1216-23.
19. Marino J, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Human Reproduction. 2004;19(10):2350-5.
20. Chaparala R, Fawole A, Ambrose N, Chapman A. Large bowel obstruction due to a benign uterine leiomyoma. Gut. 2004;53(3):386.
